This document summarizes a study that used the liquisolid technique to enhance the dissolution rate of the poorly water soluble drug ketoprofen. Several liquisolid tablet formulations were prepared using ketoprofen as the drug and propylene glycol or tween 80 as liquid vehicles. Microcrystalline cellulose and dicalcium phosphate were used as carriers and silica gel as the coating material. The liquisolid tablets showed improved flow properties and higher drug release compared to marketed ketoprofen tablets. X-ray diffraction and FTIR analysis indicated no drug-excipient interactions. The liquisolid technique was effective in enhancing the dissolution of the poorly soluble drug ketoprofen.
In-vitro in vivo dissolution correlation BCS classificationRoshan Bodhe
The document discusses in vitro in vivo correlation (IVIVC) and the Biopharmaceutical Classification System (BCS). It introduces the BCS, which classifies drugs based on their solubility and permeability. Drugs fall into four classes based on these properties, with Class I drugs being highly soluble and permeable. The document discusses factors that determine drug absorption like solubility, permeability, and dissolution. It describes methods to determine these properties and outlines the common dissolution apparatus and factors affecting dissolution testing. The goals of BCS and examples of drugs in each class are also provided.
Preformulation involves characterizing the physicochemical properties of a drug prior to formulation development. Key aspects of preformulation studied include determining solubility, stability, and bulk properties of the drug substance. Analytical methods are also developed to quantitatively analyze the drug. This information guides the selection of appropriate excipients and dosage forms that will deliver the drug safely and effectively.
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATERam C Dhakar
This document summarizes the development and evaluation of mucoadhesive microspheres for the controlled release of pioglitazone maleate. Mucoadhesive microspheres were prepared using sodium carboxymethyl cellulose (SCMC), carbopol 934P (CP), and sodium alginate (SA) as polymers via an emulsification solvent evaporation method. The microspheres were evaluated for particle size, drug entrapment efficiency, mucoadhesion, and in vitro drug release. Microspheres containing SCMC showed the smoothest surface, highest mucoadhesion and drug release over 10 hours. Overall, the study developed pioglitazone-loaded microspheres for controlled
Enhancement of dissolution rate and bioavailability of poorly soluble drugsNagaraju Ravouru
This document discusses methods to enhance the dissolution rates and bioavailability of poorly soluble drugs. It begins by noting that about 95% of new drug candidates have poor solubility and bioavailability. It then discusses the Biopharmaceutical Classification System and how Class II drugs in particular need enhanced dissolution for increased bioabsorption. Several methods to enhance dissolution are covered, including increasing drug solubility through various approaches, and increasing surface area through micronization and solid dispersions. Specific technologies like cyclodextrin complexes and nanonization are also summarized. The conclusion reiterates the importance of ongoing research to develop delivery technologies to improve insoluble drugs.
Application of preformulation consideration in the development ofArpan Dhungel
This document discusses preformulation studies for developing parenteral dosage forms. Preformulation involves studying a new drug's physicochemical properties to create stable, effective formulations. Key aspects of preformulation include assessing solubility through methods like changing pH, adding co-solvents or complexing agents, and evaluating stability under various conditions like heat, light and pH to determine a drug's degradation profile. The goal of preformulation is to obtain information to guide formulation development and ensure the drug molecule is most stable.
Solid dispersion is an effective way of improving the dissolution rate of poorly water soluble drugs and hence its bioavailability. The water soluble carriers used in preparation of solid dispersion enhance the dissolution rate of the poorly water soluble drug. This work reflects the improvement of Dissolution Characteristics as well as Bioavailability of poorly aqueous soluble drug Hydrochlorothiazide. It belongs to BCS class 2 i.e. it has poor water solubility but good permeability.
In-vitro in vivo dissolution correlation BCS classificationRoshan Bodhe
The document discusses in vitro in vivo correlation (IVIVC) and the Biopharmaceutical Classification System (BCS). It introduces the BCS, which classifies drugs based on their solubility and permeability. Drugs fall into four classes based on these properties, with Class I drugs being highly soluble and permeable. The document discusses factors that determine drug absorption like solubility, permeability, and dissolution. It describes methods to determine these properties and outlines the common dissolution apparatus and factors affecting dissolution testing. The goals of BCS and examples of drugs in each class are also provided.
Preformulation involves characterizing the physicochemical properties of a drug prior to formulation development. Key aspects of preformulation studied include determining solubility, stability, and bulk properties of the drug substance. Analytical methods are also developed to quantitatively analyze the drug. This information guides the selection of appropriate excipients and dosage forms that will deliver the drug safely and effectively.
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATERam C Dhakar
This document summarizes the development and evaluation of mucoadhesive microspheres for the controlled release of pioglitazone maleate. Mucoadhesive microspheres were prepared using sodium carboxymethyl cellulose (SCMC), carbopol 934P (CP), and sodium alginate (SA) as polymers via an emulsification solvent evaporation method. The microspheres were evaluated for particle size, drug entrapment efficiency, mucoadhesion, and in vitro drug release. Microspheres containing SCMC showed the smoothest surface, highest mucoadhesion and drug release over 10 hours. Overall, the study developed pioglitazone-loaded microspheres for controlled
Enhancement of dissolution rate and bioavailability of poorly soluble drugsNagaraju Ravouru
This document discusses methods to enhance the dissolution rates and bioavailability of poorly soluble drugs. It begins by noting that about 95% of new drug candidates have poor solubility and bioavailability. It then discusses the Biopharmaceutical Classification System and how Class II drugs in particular need enhanced dissolution for increased bioabsorption. Several methods to enhance dissolution are covered, including increasing drug solubility through various approaches, and increasing surface area through micronization and solid dispersions. Specific technologies like cyclodextrin complexes and nanonization are also summarized. The conclusion reiterates the importance of ongoing research to develop delivery technologies to improve insoluble drugs.
Application of preformulation consideration in the development ofArpan Dhungel
This document discusses preformulation studies for developing parenteral dosage forms. Preformulation involves studying a new drug's physicochemical properties to create stable, effective formulations. Key aspects of preformulation include assessing solubility through methods like changing pH, adding co-solvents or complexing agents, and evaluating stability under various conditions like heat, light and pH to determine a drug's degradation profile. The goal of preformulation is to obtain information to guide formulation development and ensure the drug molecule is most stable.
Solid dispersion is an effective way of improving the dissolution rate of poorly water soluble drugs and hence its bioavailability. The water soluble carriers used in preparation of solid dispersion enhance the dissolution rate of the poorly water soluble drug. This work reflects the improvement of Dissolution Characteristics as well as Bioavailability of poorly aqueous soluble drug Hydrochlorothiazide. It belongs to BCS class 2 i.e. it has poor water solubility but good permeability.
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug prior to formulation. The goals are to establish parameters like solubility, stability, and compatibility with excipients. Key areas discussed include solubility studies like determining pKa and performing partition coefficient experiments. Bulk characterization of properties like crystallinity, hygroscopicity and micromeritics are also covered. The document concludes with an overview of stability analysis of drug solutions and solids as well as drug-excipient compatibility testing.
The document discusses various techniques to improve the solubility of poorly soluble drugs, including salt formation, co-solvency, and particle size reduction. It focuses on using salt formation between flurbiprofen and tris(hydroxymethyl)aminomethane to increase solubility. Analytical techniques like DSC, TGA, HPLC, and UV were used to characterize the flurbiprofen-tris salt and showed improved solubility over flurbiprofen alone. The conclusion states that increasing water solubility of insoluble drugs is important for developing effective dosage forms and delivering drugs to the absorption site.
This document summarizes a study on enhancing the dissolution rate of olanzapine, an antipsychotic drug with poor water solubility, using solid dispersion techniques. The study aimed to prepare solid dispersions of olanzapine with various carriers using physical mixture, solvent evaporation, and kneading methods. Dissolution tests found that the solid dispersions significantly increased the dissolution rate of olanzapine compared to the raw drug. Carriers like PEG 4000, PEG 6000, and HP-βCD were most effective at enhancing dissolution when prepared by the kneading or solvent evaporation methods. FT-IR analysis was used to evaluate drug-carrier interactions. The results of this study demonstrate that solid dispersion is an
Dissolution and In Vitro In Vivo Correlation (IVIVC)Jaspreet Guraya
This presentation gives a bird's eye view on Dissolution in context with IVIVC. It discusses various levels of Correlations currently in practice. IVIVC are explained in light of biowaivers It also touches upon IVIVR, IVIVM etc.
This document outlines preformulation studies conducted on the drug metronidazole, including characterization of its physical properties, solubility, stability, and compatibility with excipients. Key aspects that were evaluated include particle size, bulk density, angle of repose, pH, partition coefficient, stability under various conditions like temperature, humidity and light. Drug-excipient compatibility was also studied by storing mixtures at elevated temperature and observing for physical or chemical changes. The goal of these studies is to understand the drug's characteristics and behavior to aid in rational formulation design and selection of appropriate excipients and storage conditions.
This document discusses the importance of preformulation studies in designing sustained release dosage forms. Preformulation studies provide important information about the drug substance that can be used to develop stable and bioavailable sustained release formulations. Key aspects of preformulation include determining solubility, pKa, partition coefficient, crystal properties, and compatibility with excipients. This information helps select appropriate formulation components, manufacturing processes, container closure systems and more. The overall goal of preformulation is to generate data to support the development of sustained release dosage forms that can be mass produced and provide a prolonged therapeutic effect.
The document summarizes a study on the formulation and evaluation of gastroretentive floating tablets containing cefpodoxime proxetil (CP) solid dispersions. CP has poor aqueous solubility and bioavailability. Solid dispersions of CP were prepared using skimmed milk powder as a carrier to improve solubility. Floating tablets were developed using these solid dispersions to provide prolonged gastric retention. Tablets containing solid dispersion 4 showed the fastest drug release and highest buoyancy. The study demonstrated that these floating tablets with CP solid dispersions can enhance the drug's solubility and dissolution.
Formulation and Evaluation of Liquisolid Compacts of CarvedilolIOSR Journals
The purpose of this study is to develop a novel liquisolid technique to enhance the dissolution rate of
poorly water soluble drug Carvedilol, a BCS class II drug, which is a β-blocker, by using different excipients.
The main components of a liquisolid system are a non volatile solvent, carrier and coating materials and a
disintegrant. Liquisolid system refers to the formulations that are formed by conversion of liquid drugs, drug
suspensions or drug solution in non-volatile solvents into dry, non adherent, free flowing and compressible
powder mixture by blending with suitable carrier and coating materials. Hence the dissolution step, a prerequisite
for drug absorption, is by passed and better bioavailability of poorly soluble drug is achieved.
Liquisolid tablets of carvedilol are prepared by using PEG, PG, glycerine as non volatile liquid vehicles and
Avicel PH 101 and 102, Aerosil as carrier and coating materials respectively. Optimized formulation containing
20% drug in PEG 400, with Avicel 101 as carrier and Aerosil as coating material has shown 98.4% drug
release within 20 min which is better than marketed product (CARCA 12.5mg, Intas). The DSC and X-RD
studies are performed to investigate the physicochemical properties of formulation and drug excipient
interactions. The results are found to be satisfactory
Formulation factors affecting drug absorptionshikha singh
This presentation discusses formulation factors that affect drug absorption. It identifies manufacturing variables like compression force during tablet production and granulation methods. It also discusses the influence of pharmaceutical ingredients like excipients, vehicles, diluents, and surfactants. Finally, it examines how the nature and type of the dosage form, such as solutions, suspensions, capsules and tablets, can impact drug absorption. The goal is to understand these formulation factors to develop dosage forms that allow drugs to be effectively absorbed and exert their pharmacological effects.
This document discusses drug dissolution, including definitions, theories, mechanisms, factors affecting dissolution, intrinsic dissolution rate, and in-vitro dissolution testing models. It defines dissolution as the mass transfer of a solid substance into a liquid solvent. The key theories discussed are the diffusion layer model, Danckwert's penetration theory, and the interfacial barrier model. Factors affecting dissolution include properties of the drug, test conditions, and dosage form characteristics. Common in-vitro dissolution testing models include non-sink and sink methods that utilize natural or forced convection with varying degrees of agitation.
This document describes a study that formulated liquisolid tablets of curcumin to improve its dissolution profile. Curcumin has poor water solubility and low oral bioavailability. Various liquisolid formulations were prepared using different non-volatile solvents and excipients. Evaluation tests showed the liquisolid formulations had better flow properties than direct compression tablets. In vitro dissolution studies found formulation LSC-2 had the highest curcumin release. Overall, the liquisolid technique improved curcumin's dissolution rate by increasing its surface area and wettability.
This document summarizes key parameters studied in the consolidation of pharmaceutical formulations, including diffusion parameters described by Higuchi's equation, dissolution parameters like the effects of agitation and pH, and pharmacokinetic parameters like Cmax, Tmax, and AUC. It also discusses the Heckel plot and similarity factors f1 and f2 for comparing drug release profiles.
The document discusses a study on enhancing the solubility of loratadine, a class II drug with low solubility and high permeability, through solid dispersion techniques. Loratadine's solubility decreases with increasing pH. The study prepares solid dispersions of loratadine with β-cyclodextrin, HPC, and PEG-6000 and finds their solubility is greatly improved, especially at higher pH levels. Solubility is tested in buffers from pH 1.2 to 7.4. The co-precipitation method provides better solubility results than physical mixing for the dispersions tested.
Dissolution by Dr. Neeraj Mishra professor pharmaceuticsNeeraj Mishra
The document discusses dissolution, which is the process by which a solid substance enters the solvent phase to form a solution. Dissolution is important for drug absorption from oral dosage forms and can be the rate-limiting step. Dissolution testing is used for quality control, formulation development, and correlating in vitro dissolution to in vivo bioavailability. Theories of dissolution include diffusion layer models and surface renewal models. Factors that affect dissolution include drug properties, dosage form factors, particle size, polymorphism, salt formation, and lipid solubility.
EFFECT OF PHYSICOCHEMICAL NATURE OF DRUG ON DISSOLUTIONN Anusha
pH - PARTITION THEORY, LIPID SOLUBILITY OF DRUGS, DRUG DISSOLUTION AND PH, SALTS, CRYSTAL FORM, DRUG STABILITY AND HYDROLYSIS IN GIT, COMPLEXATION, ADSORPTION
Techniques for enhancement of dissolution rateSagar Savale
The document discusses various techniques to enhance the dissolution rate of drugs, which is important for predicting bioavailability. It describes the process of dissolution and factors that influence the rate based on the Noyes-Whitney equation. Several methods are covered, including increasing surface area through particle size reduction, using surfactants, solid dispersions, polymorphism, molecular encapsulation, salt formation, and nanosuspensions. Enhancing dissolution rate can improve drug efficacy by increasing bioavailability.
The document discusses key concepts in preformulation studies for drug development. Preformulation involves characterizing important physical and chemical properties of drug molecules like particle size, solubility, polymorphism, and stability. These properties influence dosage form design and development. The document outlines several properties that must be evaluated such as partition coefficient, hydrolytic degradation potential, and drug-excipient interactions to optimize formulation.
Dissolution Enhancement of BCS Class 4 Dssrugs Using Quality by Design Approa...inventionjournals
Solid dispersion is one of the vastly accepted and practically economical processes in bioavailability enhancement study. The present investigation deals mostly with increase in solubility and dissolution rate of BCS class 4 drugs for enhancement of oral bioavailability. For the same solid dispersion were prepared and analyzed for appropriate concentration of drug polymer ratio by phase solubility analysis. The solvent evaporation study widely accepted due to its efficient solid dispersion in lesser efforts. The study designs were prepared with specific concentration of drug and polymer ratio with the help of high throughput model i.e. Central Composite Design (by Design Expert trial copy) by specific design of experiment with full factorial design (DOE). The fixed variables were concentration of polymers and dependant variables were dissolution and permeability across bio-membrane in in-vitro model. The prepared dispersion investigated for dissolution and permeability improvement using USP Type II apparatus and modified everted gut sac model which leads to improvement of quality of whole formulation with Quality by design efficiently.
DESIGN AND ASSESSMENT OF COLON SPECIFIC DRUG DELIVERY OF CELECOXIB USING PU...Lakshmi
The document summarizes the design and assessment of a colon-specific drug delivery system for celecoxib using pulsincap technique. Celecoxib microcrystals were prepared using a rapid solvent change method and evaluated. The microcrystals were then used to prepare pulsincaps containing hydrogel plugs to provide a lag time before drug release. In vitro drug release studies were conducted on the pulsincaps to assess their ability to deliver celecoxib in a pulsatile manner to the colon. The aim was to improve solubility, target delivery to the colon, and minimize dosing frequency for the treatment of rheumatoid arthritis.
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug prior to formulation. The goals are to establish parameters like solubility, stability, and compatibility with excipients. Key areas discussed include solubility studies like determining pKa and performing partition coefficient experiments. Bulk characterization of properties like crystallinity, hygroscopicity and micromeritics are also covered. The document concludes with an overview of stability analysis of drug solutions and solids as well as drug-excipient compatibility testing.
The document discusses various techniques to improve the solubility of poorly soluble drugs, including salt formation, co-solvency, and particle size reduction. It focuses on using salt formation between flurbiprofen and tris(hydroxymethyl)aminomethane to increase solubility. Analytical techniques like DSC, TGA, HPLC, and UV were used to characterize the flurbiprofen-tris salt and showed improved solubility over flurbiprofen alone. The conclusion states that increasing water solubility of insoluble drugs is important for developing effective dosage forms and delivering drugs to the absorption site.
This document summarizes a study on enhancing the dissolution rate of olanzapine, an antipsychotic drug with poor water solubility, using solid dispersion techniques. The study aimed to prepare solid dispersions of olanzapine with various carriers using physical mixture, solvent evaporation, and kneading methods. Dissolution tests found that the solid dispersions significantly increased the dissolution rate of olanzapine compared to the raw drug. Carriers like PEG 4000, PEG 6000, and HP-βCD were most effective at enhancing dissolution when prepared by the kneading or solvent evaporation methods. FT-IR analysis was used to evaluate drug-carrier interactions. The results of this study demonstrate that solid dispersion is an
Dissolution and In Vitro In Vivo Correlation (IVIVC)Jaspreet Guraya
This presentation gives a bird's eye view on Dissolution in context with IVIVC. It discusses various levels of Correlations currently in practice. IVIVC are explained in light of biowaivers It also touches upon IVIVR, IVIVM etc.
This document outlines preformulation studies conducted on the drug metronidazole, including characterization of its physical properties, solubility, stability, and compatibility with excipients. Key aspects that were evaluated include particle size, bulk density, angle of repose, pH, partition coefficient, stability under various conditions like temperature, humidity and light. Drug-excipient compatibility was also studied by storing mixtures at elevated temperature and observing for physical or chemical changes. The goal of these studies is to understand the drug's characteristics and behavior to aid in rational formulation design and selection of appropriate excipients and storage conditions.
This document discusses the importance of preformulation studies in designing sustained release dosage forms. Preformulation studies provide important information about the drug substance that can be used to develop stable and bioavailable sustained release formulations. Key aspects of preformulation include determining solubility, pKa, partition coefficient, crystal properties, and compatibility with excipients. This information helps select appropriate formulation components, manufacturing processes, container closure systems and more. The overall goal of preformulation is to generate data to support the development of sustained release dosage forms that can be mass produced and provide a prolonged therapeutic effect.
The document summarizes a study on the formulation and evaluation of gastroretentive floating tablets containing cefpodoxime proxetil (CP) solid dispersions. CP has poor aqueous solubility and bioavailability. Solid dispersions of CP were prepared using skimmed milk powder as a carrier to improve solubility. Floating tablets were developed using these solid dispersions to provide prolonged gastric retention. Tablets containing solid dispersion 4 showed the fastest drug release and highest buoyancy. The study demonstrated that these floating tablets with CP solid dispersions can enhance the drug's solubility and dissolution.
Formulation and Evaluation of Liquisolid Compacts of CarvedilolIOSR Journals
The purpose of this study is to develop a novel liquisolid technique to enhance the dissolution rate of
poorly water soluble drug Carvedilol, a BCS class II drug, which is a β-blocker, by using different excipients.
The main components of a liquisolid system are a non volatile solvent, carrier and coating materials and a
disintegrant. Liquisolid system refers to the formulations that are formed by conversion of liquid drugs, drug
suspensions or drug solution in non-volatile solvents into dry, non adherent, free flowing and compressible
powder mixture by blending with suitable carrier and coating materials. Hence the dissolution step, a prerequisite
for drug absorption, is by passed and better bioavailability of poorly soluble drug is achieved.
Liquisolid tablets of carvedilol are prepared by using PEG, PG, glycerine as non volatile liquid vehicles and
Avicel PH 101 and 102, Aerosil as carrier and coating materials respectively. Optimized formulation containing
20% drug in PEG 400, with Avicel 101 as carrier and Aerosil as coating material has shown 98.4% drug
release within 20 min which is better than marketed product (CARCA 12.5mg, Intas). The DSC and X-RD
studies are performed to investigate the physicochemical properties of formulation and drug excipient
interactions. The results are found to be satisfactory
Formulation factors affecting drug absorptionshikha singh
This presentation discusses formulation factors that affect drug absorption. It identifies manufacturing variables like compression force during tablet production and granulation methods. It also discusses the influence of pharmaceutical ingredients like excipients, vehicles, diluents, and surfactants. Finally, it examines how the nature and type of the dosage form, such as solutions, suspensions, capsules and tablets, can impact drug absorption. The goal is to understand these formulation factors to develop dosage forms that allow drugs to be effectively absorbed and exert their pharmacological effects.
This document discusses drug dissolution, including definitions, theories, mechanisms, factors affecting dissolution, intrinsic dissolution rate, and in-vitro dissolution testing models. It defines dissolution as the mass transfer of a solid substance into a liquid solvent. The key theories discussed are the diffusion layer model, Danckwert's penetration theory, and the interfacial barrier model. Factors affecting dissolution include properties of the drug, test conditions, and dosage form characteristics. Common in-vitro dissolution testing models include non-sink and sink methods that utilize natural or forced convection with varying degrees of agitation.
This document describes a study that formulated liquisolid tablets of curcumin to improve its dissolution profile. Curcumin has poor water solubility and low oral bioavailability. Various liquisolid formulations were prepared using different non-volatile solvents and excipients. Evaluation tests showed the liquisolid formulations had better flow properties than direct compression tablets. In vitro dissolution studies found formulation LSC-2 had the highest curcumin release. Overall, the liquisolid technique improved curcumin's dissolution rate by increasing its surface area and wettability.
This document summarizes key parameters studied in the consolidation of pharmaceutical formulations, including diffusion parameters described by Higuchi's equation, dissolution parameters like the effects of agitation and pH, and pharmacokinetic parameters like Cmax, Tmax, and AUC. It also discusses the Heckel plot and similarity factors f1 and f2 for comparing drug release profiles.
The document discusses a study on enhancing the solubility of loratadine, a class II drug with low solubility and high permeability, through solid dispersion techniques. Loratadine's solubility decreases with increasing pH. The study prepares solid dispersions of loratadine with β-cyclodextrin, HPC, and PEG-6000 and finds their solubility is greatly improved, especially at higher pH levels. Solubility is tested in buffers from pH 1.2 to 7.4. The co-precipitation method provides better solubility results than physical mixing for the dispersions tested.
Dissolution by Dr. Neeraj Mishra professor pharmaceuticsNeeraj Mishra
The document discusses dissolution, which is the process by which a solid substance enters the solvent phase to form a solution. Dissolution is important for drug absorption from oral dosage forms and can be the rate-limiting step. Dissolution testing is used for quality control, formulation development, and correlating in vitro dissolution to in vivo bioavailability. Theories of dissolution include diffusion layer models and surface renewal models. Factors that affect dissolution include drug properties, dosage form factors, particle size, polymorphism, salt formation, and lipid solubility.
EFFECT OF PHYSICOCHEMICAL NATURE OF DRUG ON DISSOLUTIONN Anusha
pH - PARTITION THEORY, LIPID SOLUBILITY OF DRUGS, DRUG DISSOLUTION AND PH, SALTS, CRYSTAL FORM, DRUG STABILITY AND HYDROLYSIS IN GIT, COMPLEXATION, ADSORPTION
Techniques for enhancement of dissolution rateSagar Savale
The document discusses various techniques to enhance the dissolution rate of drugs, which is important for predicting bioavailability. It describes the process of dissolution and factors that influence the rate based on the Noyes-Whitney equation. Several methods are covered, including increasing surface area through particle size reduction, using surfactants, solid dispersions, polymorphism, molecular encapsulation, salt formation, and nanosuspensions. Enhancing dissolution rate can improve drug efficacy by increasing bioavailability.
The document discusses key concepts in preformulation studies for drug development. Preformulation involves characterizing important physical and chemical properties of drug molecules like particle size, solubility, polymorphism, and stability. These properties influence dosage form design and development. The document outlines several properties that must be evaluated such as partition coefficient, hydrolytic degradation potential, and drug-excipient interactions to optimize formulation.
Dissolution Enhancement of BCS Class 4 Dssrugs Using Quality by Design Approa...inventionjournals
Solid dispersion is one of the vastly accepted and practically economical processes in bioavailability enhancement study. The present investigation deals mostly with increase in solubility and dissolution rate of BCS class 4 drugs for enhancement of oral bioavailability. For the same solid dispersion were prepared and analyzed for appropriate concentration of drug polymer ratio by phase solubility analysis. The solvent evaporation study widely accepted due to its efficient solid dispersion in lesser efforts. The study designs were prepared with specific concentration of drug and polymer ratio with the help of high throughput model i.e. Central Composite Design (by Design Expert trial copy) by specific design of experiment with full factorial design (DOE). The fixed variables were concentration of polymers and dependant variables were dissolution and permeability across bio-membrane in in-vitro model. The prepared dispersion investigated for dissolution and permeability improvement using USP Type II apparatus and modified everted gut sac model which leads to improvement of quality of whole formulation with Quality by design efficiently.
DESIGN AND ASSESSMENT OF COLON SPECIFIC DRUG DELIVERY OF CELECOXIB USING PU...Lakshmi
The document summarizes the design and assessment of a colon-specific drug delivery system for celecoxib using pulsincap technique. Celecoxib microcrystals were prepared using a rapid solvent change method and evaluated. The microcrystals were then used to prepare pulsincaps containing hydrogel plugs to provide a lag time before drug release. In vitro drug release studies were conducted on the pulsincaps to assess their ability to deliver celecoxib in a pulsatile manner to the colon. The aim was to improve solubility, target delivery to the colon, and minimize dosing frequency for the treatment of rheumatoid arthritis.
The aim of the present research was formulation and evaluation of anti-inflammatory drug dexibuprofen loaded chitosan-based polymeric nanoparticles (NPs) for the controlled release of dexibuprofen using different concentrations of chitosan and surfactant. Materials and Methods: Dexibuprofen, a nonsteroidal anti-inflammatory drug was encapsulated with the polymer by emulsion-droplet coalescence method (DNP1-DNP5). The NPs were characterized by drug content, particle size, zeta potential, encapsulation efficiency, and in vitro drug release. Result: DNP3 was selected as best formulation due to its ideal particle size (437.6 nm), high entrapment efficiency (88.54%), and desirable drug release (99.81 ± 0.92% at the end of 24 h). Conclusion: The present study can be concluded that the newly formulated controlled release nanoparticulate drug delivery system of dexibuprofen may be ideal and effective in the management of pain due to arthritis by allowing the drug to release continuously for 24 h.
Improved Wetting For Improved Solubility and Dissolution of Candesartan Cil...iosrphr_editor
This document summarizes a study that evaluated liquisolid compacts as a method to improve the solubility and dissolution of candesartan cilexetil, a poorly soluble antihypertensive drug. Liquisolid compacts were prepared using candesartan cilexetil and two liquid vehicles - Tween 20 (a surfactant) and Transcutol (a modified surfactant) - at various ratios from 1:1 to 1:9. The compacts were evaluated for drug content, saturation solubility in different media, and dissolution in various media. Both liquisolid systems showed improved solubility and dissolution compared to pure drug, with the Transcutol system generally
The document discusses the liquisolid technique for enhancing drug dissolution and delivery. Liquisolid systems convert liquid drugs or drug suspensions into dry, flowable powders by mixing the liquid with select carrier and coating materials. This improves drug release characteristics and oral bioavailability. The key steps are: (1) dissolving the drug in a non-volatile solvent, (2) mixing this liquid medication with carrier material to absorb the liquid internally and externally, (3) adding a coating material to produce a dry, free-flowing powder, and (4) compressing the powder into tablets or filling capsules. Evaluation studies showed the liquisolid tablets had higher drug release and bioavailability compared to commercial formulations.
Design and Development of Effervescent Floating Tablet Dapagliflozinijtsrd
The objective of the present study was to formulate and evaluate Effervescent Floating Tablet of Dapagliflozin for the treatment of antidepressant agent. Tablets were prepared by direct compression using directly compressible polymers such as HPMC K4M, and Carbopol 934 were evaluated for drug excipient compatibility, density, buoyancy test, swelling study, drug content and In Vitro release profile. Sodium bicarbonate and citric acid were used producing effervescent base for buoyancy of tablets. Analysis of drug release from tablet indicates drug release by zero order, first order rate kinetics. No significant change was observed in physical appearance, drug content, floatability or in vitro dissolution pattern after storage at 450C 750C RH for three months. Samadhan Mali | Shweta Gedam | Swati Talele | Anil Jadhav "Design and Development of Effervescent Floating Tablet Dapagliflozin" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-5 , August 2020, URL: https://www.ijtsrd.com/papers/ijtsrd31674.pdf Paper Url :https://www.ijtsrd.com/pharmacy/pharmaceutics/31674/design-and-development-of-effervescent-floating-tablet-dapagliflozin/samadhan-mali
The document discusses solid dispersions as a promising approach for improving the solubility and bioavailability of poorly soluble drugs. Solid dispersions involve dispersing a drug in an inert hydrophilic carrier through melting, solvent, or melting-solvent methods. This produces a high surface area drug particles that dissolve faster. Characterization techniques like particle size analysis, dissolution testing, infrared spectroscopy, and X-ray diffraction are used to analyze the interactions between drug and carrier and the state of the drug in the solid dispersion. The advantages of solid dispersions include reduced particle size, improved wettability, increased porosity, and transforming crystalline drugs into amorphous states with higher solubility. Alternative preparation techniques like lyophilization and spraying on
The document provides an overview of preformulation studies, which are conducted to determine the physicochemical properties of new drug substances prior to formulation development. Key aspects covered include definition of preformulation, factors considered, objectives, outcomes, common tests like solubility and stability studies, and techniques involved. Specifically, the document discusses solubility analysis methods, factors affecting solubility like pH and temperature, and importance of solubility determination. It also covers common degradation pathways like oxidation and hydrolysis, and approaches to prevent or minimize degradation.
SOLUBILITY ENHANCEMENT OF NEBIVOLOL BY SOLID DISPERSION TECHNIQUESriramNagarajan17
The document summarizes a study on improving the solubility of the poorly water soluble drug Nebivolol using solid dispersion technique. Various solid dispersions of Nebivolol with carriers PEG 6000 and PVP K30 were prepared using fusion and solvent evaporation methods. Phase solubility studies showed PVP K30 had higher solubilizing effect and binding affinity compared to PEG 6000. Saturation solubility studies showed Nebivolol had higher solubility in acidic conditions and methanol compared to water. FTIR analysis indicated no chemical interactions between Nebivolol and the carriers in the solid dispersions. In vitro dissolution studies showed the PVP K30 solid dispersion with ratio 1:5 prepared
The document discusses preformulation studies for solids. The objectives are to develop a stable, safe and effective dosage form with maximum bioavailability. Preformulation testing characterizes the physical, chemical and other properties of a new drug to aid in dosage form development. Studies include analyzing the drug's crystallinity, polymorphism, particle size, solubility, stability and compatibility with excipients. Analytical techniques used include microscopy, spectroscopy, chromatography and thermal analysis to understand the drug's properties and develop an optimal dosage form.
Importance of partition coefficient, solubility and dissociation on pre-formu...SHANE_LOBO145
This document discusses the importance of preformulation studies, specifically focusing on partition coefficient, dissociation constant, and solubility. It defines these key terms and explains their significance in determining drug absorption and developing drug formulations. The partition coefficient indicates a drug's lipophilicity and ability to cross cell membranes. The dissociation constant and Henderson-Hasselbalch equation are used to predict drug ionization and site of absorption in the gastrointestinal tract. Solubility is critical for bioavailability and influences formulation strategies to increase or decrease a drug's aqueous solubility. Understanding these physicochemical properties is essential for designing an optimal drug delivery system.
This document provides a synopsis for a Master's thesis project titled "Formulation and Evaluation of Fast Dissolving Films of Lisinopril". The project aims to develop fast dissolving films of the hypertension drug Lisinopril to improve patient compliance. Literature on fast dissolving drug delivery systems and films has been reviewed. The planned work involves preparing Lisinopril films using natural and synthetic polymers through various techniques and evaluating the films for properties like drug content, dissolution, and pharmacodynamics. If successful, the fast dissolving Lisinopril films could provide quick action and ease of administration benefits for hypertension patients.
The document summarizes the biopharmaceutical classification system (BCS), which classifies drugs into four classes based on their aqueous solubility and permeability characteristics. The BCS takes into account solubility, permeability and dissolution rate to predict a drug's absorption and bioavailability. Class I drugs are highly soluble and permeable; Class II are poorly soluble but highly permeable; Class III are highly soluble but poorly permeable; Class IV are both poorly soluble and permeable. The choice of dissolution medium depends on the drug class and aims to simulate gastrointestinal conditions. Understanding a drug's BCS class helps predict its in vivo performance and determine if in vitro dissolution testing can substitute for in vivo bioequivalence studies.
Formulation and Evaluation of Sublingual Tablets of Asenapine Maleate By 32 F...PRASANTAKUMARMOHAPAT3
Objectives: The aim of this work was to formulate and evaluate sublingual tablets of Asenapine
maleate for the treatment of schizophrenia and the treatment of manic episodes associated with
bipolar I disorder. Methods: In the present work, the bitter taste of Asenapine maleate was
masked by using Kyron T-114 in 1:1.5 ratio. The Drug-Resin Complex was formulated as
sublingual tablets using Cross Povidone (X1) and Avicel PH102 (X2) by direct compression
method. The sublingual tablets were evaluated such as thickness, hardness, % Friability,
Wetting time, disintegration time, Water absorption ratio and % CDR.Results: In this study, the
fast release of tablets depends on the concentration of Cross Povidone (X1) and Avicel PH102
(X2). The selected formulation showed the fastest release of the tablets in 54 s. Stability study
was performed by taking an optimized formulation and it was observed stable. The sublingual
tablets showed acceptable results in all studies.Conclusion: The results indicate that the
formulation can be used for the treatment of schizophrenia and the treatment of manic episodes
associated with bipolar I disorder. Moreover, Asenapine maleate as sublingual tablets may
overcome the first pass effect, gives better bioavailability, rapid onset of action and patient
compliance.
The document discusses preformulation studies that are conducted prior to developing a dosage form for a new drug. The objectives are to determine the drug's physicochemical properties, solubility, stability, and compatibility with excipients. Key tests include solubility studies under various conditions, stability studies of solid and liquid states under stress conditions like heat, light and pH, and chemical characterization of properties like oxidation and hydrolysis. The outcomes aim to develop a formulation that safely delivers the drug to the site of action as intended.
Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piro...ijtsrd
The solubility behavior of drugs remains one of the most exigent aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Among all the newly discovered chemical entities, about 40 45 drugs fail to reach market due to their poor water solubility. Because of solubility problem, bioavailability of drugs gets affected and hence solubility enhancement becomes necessary. In present study the attempts have been made to increase the dissolution of BCS class 2 drug Piroxicam using hydrophilic polymers namely polyethylene glycol PEG 6000 and sodium lauryl sulphate as a surfactant by using solid dispersion technique. In solid dispersion microwave induced solid dispersion and conventional fusion method is compared. Drug polymer complex was prepared using batch method. Maximum dissolution rate was obtained of the complex prepared from Piroxicam PEG6000 SLS . A successful solubility enhancement of drug complex was confirmed by taking drug release in phosphate buffer pH 6.8. The drug was characterized according to different compendial methods, on the basis of identification by UV spectroscopy, organoleptic properties and other tests. After that among the all formulation batches, solid dispersion F16 was selected for further tablet formulation batches, nine formulations were developed and studied. The values of pre compression parameters was evaluated, results were within prescribed limits and indicated good free flowing properties. The data obtained of post compression parameters such as weight variation, hardness, friability, wetting time, water absorption ratio, content uniformity, disintegration time and dissolution was found to superior over conventional formulation. The F9 batch with disintegrating time 10 ± 0.52 second and dissolution 93.20 ± 0.61 was selected as optimized formulation and was found superior over other formulation. Batch F9 was also subjected to stability studies for three months and was tested for its disintegrating time, drug contents and dissolution behavior monthly. F9 formulation after stability study was found to be stable. Mr. Yennuwar Dhiresh Pramod | Mr. Sujit Kakade | Mrs. Trusha Shangrapawar | Dr. Ashok Bhosale "Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piroxicam using Solid Dispersion Technique" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-5 , August 2022, URL: https://www.ijtsrd.com/papers/ijtsrd50422.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/50422/formulation-development-and-evaluation-of-fast-disintegrating-tablet-of-piroxicam-using-solid-dispersion-technique/mr-yennuwar-dhiresh-pramod
Formulation And Evaluation of Mucoadhesive Tablets of Carvedilol Using Natura...Nausheen Fatima
This document summarizes the formulation and evaluation of mucoadhesive tablets containing carvedilol using natural binders such as chitosan and guar gum. Eight formulations of carvedilol mucoadhesive tablets were prepared using different polymer ratios and evaluated for properties such as drug release, swelling, mucoadhesion and compatibility. The optimized formulation F4 containing carvedilol, Carbopol 940P, chitosan in a 3:1 ratio showed maximum drug release of 92% over 7 hours, highest swelling of 62% after 6 hours, and greatest mucoadhesive strength of 0.95N. The results suggest this optimized formulation can prolong drug release and potentially enhance bioavailability by adhering to the bucc
This document describes a study that prepared and evaluated carvedilol-loaded solid lipid nanoparticles (SLNs) for oral drug delivery. Compritol 888 ATO (COMP) was selected as the lipid material based on its solubility parameter relative to carvedilol. Design of experiments was used to optimize the concentrations of COMP and Poloxamer 188 surfactant in blank SLNs and carvedilol-loaded SLNs. The optimized formulation containing 7.5% COMP, 5.0% Poloxamer 188, and 1.11% carvedilol had a particle size of 161 nm and 94.8% drug entrapment efficiency. In vitro studies showed the SLNs protected carvedilol from acidic environments and
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Azure Interview Questions and Answers PDF By ScholarHat
Keto keto
1. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
1 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
Available online at www.jpbms.info
JPBMS
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES
Enhancement of Dissolution Rate and Micromeritics of Poorly Soluble Drug Ketoprofen by Liquisolid
Technique
*Vijaykumar Nagabandi1, Ramarao Tadikonda2, K.N. Jayaveera3
1M.Pharmacy, Department of Pharmaceutics, Vaageswari College of Pharmacy, Karimnagar, A.P, India
2 M.Pharm,Ph.D, Blue Birds College of Pharmacy, Hanamkonda, India.
3 Msc.Ph.D, Jawaharlal Nehru Technological University, Ananthapur, India.
Abstract:
Liquisolid technique is novel concept for delivery of drugs through oral route. This approach of delivering drugs is mostly
suitable for lipophilic drugs and poorly or water insoluble drugs. It involves dissolving water insoluble drugs in non-
volatile solvents and converting into acceptably flowing and compressible powders. The main objective of present
investigation was to enhance the dissolution rate of water insoluble drug ketoprofen by using liquisolid technique. Several
liquisolid tablets were prepared by using different carrier materials such as microcrystalline cellulose, and dicalcium
phosphate, and coating material such as silica gel, respectively. Propylene glycol and tween80 were used as non volatile
water miscible liquid vehicle. The ratio of carrier to coating material was kept constant in all formulations at 20 to 1.
Before compression, powdered mass were evaluated for various parameters like flow properties, content uniformity etc.
All the prepared formulations were compressed using 12mm punch after addition of 5 % Sodium starch glycolate (super
disintegrating agent) to each formulation. The formulated liquisolid tablets were evaluated for post compression
parameters such as weight variation, hardness, friability, drug content uniformity, and disintegration time. The in-vitro
release characteristics of the pure drug, drug from marketed tablets (as reference) and liquisolid technique (test sample),
were studied. X-Ray Diffraction (XRD) and Fourier-Transform infrared spectroscopy (FT-IR) were performed. The results
showed that liquisolid formulations of ketoprofen exhibited good micromeritic properties and higher percentage of drug
release than marketed formulation. And it was concluded that there was no interaction between drug and excipients.
Keywords: Liquisolid compacts, Ketoprofen, Dissolution, content uniformity.
Introduction:
Dissolution remains a critical factor for absorption of
drugs and especially so with water insoluble drugs. [1]
Therapeutic effectiveness of a drug depends upon the
bioavailability which is dependent on the solubility and
dissolution rate of drug molecules.. Water insoluble drugs
will be inherently released at a slow rate owing to their
limited solubility within the GI contents. The dissolution
rate is often the rate determining step in the drug
absorption of BCS Class II and Class IV drugs. The
challenge for these drugs is to enhance the rate of
dissolution. This in turn subsequently improves
absorption and bioavailability. Formulation methods
targeted at dissolution enhancement of poorly soluble
substances are continuously introduced. [2] Liquisolid
technique is one of the most promising novel techniques
amongst various methods to overcome dissolution
problem. [3-8]
In liquisolid compact, a liquid medication is converted into
acceptably flowing and compactible powder forms. The
term ‘liquid medication’ implies liquid lipophilic (oily)
drug and solution or suspension of poorly water soluble
drugs carried in suitable water miscible non-volatile liquid
systems termed the liquid vehicle. By simple blending with
suitable excipients ‘carrier and coating materials’, the
liquid medication may be converted into a dry-looking,
non-adherent, free flowing and readily compactible
powder.[9]
The technique of liquisolid compacts has been successfully
employed to improve the in vitro release of poorly water
soluble drugs such as carbamazepine, [10] famotidine, [11]
piroxicam,[4] indomethacin, [5] hydrocortisone, [2]
naproxen, [7] furosemide, [12] and prednisolone. [10]
Ketoprofen, (RS) 2-(3-benzoylphenyl)-propionic acid, is
one of the propionic acid class of non-steroidal anti-
inflammatory drug (NSAID) with analgesic and antipyretic
effects. The major problem associated with the
formulation and effectiveness of the ketoprofen is its
variable oral absorption due to insufficient aqueous
solubility at gastrointestinal pH, thus making dissolution
the rate-determining step in the gastric absorption of
ketoprofen. [13] Therefore, ketoprofen establishes a good
candidate for testing the potential of rapid-release
liquisolid compacts
The main objective of this work is to develop and explore a
new formulation to enhance the bioavailability of a highly
permeable and a poorly soluble non steroidal anti-
inflammatory drug ketoprofen by following liquisolid
compacts. And to compare the invitro drug release profile
of formulated liquisolid tablets with marketed
conventional tablet.
ISSN NO- 2230 - 7885
Research article
2. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
2 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
Materials and methods:
Materials
Ketoprofen was generously provided by Ranbaxy (India).
Microcrystalline Cellulose and Silica gel were generously
provided by Okasa Pharmaceuticals (India). Propylene
glycol, tween 80 and DCP were purchased from SD Fine
Chemicals (India). All other reagents and chemicals were
of analytical grade.
Methods:
Use of a mathematical model to design liquisolid
compacts
The formulation design of liquisolid systems was done in
accordance with the new mathematical model. [9] In this
study, propylene glycol and tween 80 were used as a
liquid vehicle, Mycro crystalline Cellulose (MCC) and
Dicalcium Phosphate (DCP), were used as carrier
materials and Silica gel was used as coating material,
respectively.
The concentration of the drug in solvent and the carrier:
coating ratio was kept constant in all formulations.
According to new theories, the carrier and coating powder
materials can retain only certain amounts of liquid while
maintaining acceptable flowability and compressibility.
The excipient ratio R of the powder is defined as
R = Q / q------- (1)
Where R is the ratio of the weight of carrier (Q) and
coating (q) materials present in the formulation. The
liquid load factor (Lf) is defined as the ratio of the weight
of liquid medication (W) to the weight of the carrier
powder (Q) in the system, which should be present in an
acceptably flowing and compressible liquisolid system, i.e.
Lf = W / Q------- (2)
Table 1: Formulations of Liquisolid Compacts
Determination of solubility
Saturated solutions were prepared by adding excess
ketoprofen to the solvent and shaking on a shaker for 48 h
at 25°C with constant vibration. The solutions were
filtered through a 0.45 micron filter, diluted with water,
and analyzed with a Shimadzu 1700 UV-Vis
spectrophotometer at 260 nm with respect to a blank
sample (the blank sample was a solution containing the
same concentration used without the drug).
Determination was carried out in triplicate for each
sample to calculate the solubility of Ketoprofen.
Preparation of liquisolid compacts
Calculated quantities of ketoprofen and solvent were
accurately weighed in a 20-mL glass beaker and then
mixed well. The resulting medication was incorporated
into calculated quantities of carrier and coating materials.
The mixing process was carried out in three steps[9]. In the
first, the system was blended at an approximate mixing
rate of one rotation per second for approximately one
minute in order to evenly distribute liquid medication in
the powder. In the second, the liquid/powder admixture
was evenly spread as a uniform layer on the surface of a
mortar and left standing for approximately 5 min to allow
the drug solution to be absorbed inside powder particles.
In the third, the powder was scraped off the mortar
surface using an aluminum spatula. Then Carrier: Coating
material (20:1) was added to this mixture and blended in a
mortar. This provided the final formulation that was
compressed into tablets using a 12mm single punch tablet
compression machine after addition of 5% sodium starch
glycolate as disintegrating agent.
Precompression studies:
Flow properties
Flow properties of liquisolid formulation were studied by
angle of repose, Carr's index, and Hausner's ratio. [13]
Each analysis was carried out in triplicate. Bulk density
measurements were carried by placing a fixed weight of
powder in a graduated cylinder, and the volume occupied
was measured and the initial bulk density was calculated.
The cylinder was then tapped at a constant velocity until a
constant volume was obtained. The tapped density was
then calculated. The angle of repose was calculated by the
fixed-height cone method. All studies were done in
triplicate.
X-ray powder diffraction (XRD)
The cavity of the metal sample holder of the X-ray
diffractometer was filled with ground sample powder and
then smoothed with a spatula. X-ray diffraction pattern of
ketoprofen samples was obtained using the X-ray
diffractometer (Siemens, Model D5000, Germany) at 40
kV, 30 mA and a scanning speed of 4degree/min over the
range 10–80 (2θ), using Cu radiation of wavelength
1.5405 Å.
Infra red spectra analysis
The infra red spectra of formulations were recorded by
the KBr method using a Fourier transform infrared
Formulations Drug Solvent Carrier Coating material Disintegrating
agent
Total weight Loading
factor (Lf))
F1 100mg PG-
55mg
MCC-
330mg
Silica gel-16.5
mg
SSG –
25mg
526.5mg 0.166
F2 100mg PG-
55mg
DCP-325mg Silica gel-16.25
mg
SSG –
25mg
521.25mg 0.169
F3 100mg Tween 80-
60 mg
MCC-
340mg
Silica gel-17mg SSG –
26mg
543 mg 0.176
F4 100mg Tween 80-
60mg
DCP-332mg Silica gel-16.6
mg
SSG –
25mg
533.6mg 0.180
3. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
3 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
spectrophotometer (FTIR-8400s). A base-line correction
was made using dried potassium bromide and then the
spectrum of the pure drug, liquisolid system was obtained.
Content uniformity studies
The granules were crushed and powder containing 100
mg of Ketoprofen was dissolved in 100ml of methanol. The
solution was passed through a whatmann (NO.1) filter and
analyzed spectrophotometrically at 260nm after sufficient
dilution with Phosphate buffer pH 7.4.
Evaluation of liquisolid compacts
The hardness of liquisolid compacts was determined using
a Pfizer hardness tester (Pfizer). The mean hardness of
each formula was determined. The friability of prepared
liquisolid compacts was determined using a digital tablet
friability tester (Roche).
In vitro drug release studies
Studies were done on a six-station USP dissolution
apparatus I (Electrolab). All batches of tablets were
evaluated (n = 3) using 900 mL of 7.4 pH Phosphate buffer.
Temperature was maintained at 37 ± 0.5°C throughout the
study and stirring was done at 50 rpm. Samples were
periodically collected, filtered through a 0.45 micron filter,
and replaced with fresh dissolution medium. After
filtration through Whatman filter paper 41, the
concentration of ketoprofen was determined
spectrophotometrically at 260 nm (Shimadzu 1700 UV-Vis
Spectrophotometer). The actual amount of released drug
was determined from the calibration curve (n = 3).
Results & Discussion:
Application of new mathematical model for design of
liquisolid systems
Ketoprofen was selected as model drug for this study as it
is poorly soluble in water and thus ideal candidate for
evaluating rapid release potential of liquisolid tablets.
Liquisolid hypothesis states that drug candidate dissolved
in liquid nonvolatile vehicle and incorporated into carrier
material having porous structure and closely matted fibers
in its interior, phenomenon of both adsorption and
absorption occurs. This concludes that drug in the form of
liquid medication is absorbed initially in the interior of
particles of carrier and after saturation of this process it
gets adsorbed into internal and external surfaces of
carrier. Coating materials such as silica gel which have
high adsorptivity and grater surface area lead the
liquisolid systems desirable flow properties. [16]
Determination of Solubility of Ketoprofen in propylene
glycol and twwen 80
Determination of solubility is most important aspect in
formulation of liquisolid systems. It is needed ascertain
formation of molecular dispersion of the drug in non-
volatile solvent. The solubility of ketoprofen in propylene
glycol and tween 80 was found to be 112.24 ± 0.1 mg/ml
and 101.12 + 0.1 mg/ml respectively.
Precompression studies for liquisolid systems
Flow properties: Results of angle of repose, consolidation
index and hausner’s ratio are given in the table no 2. Flow
properties are the important concern in the formulation
and industrial production of tablet dosage form. Angle of
repose is characteristic to the flow rate of powder. In
general, values of angle of repose≥ 40 ° indicate powders
with poor flowability. The results are according to this
statement. Also results of Carr’s index and Hausner’s ratio
show good flow behavior.
Table 2: Results of Angle of repose, Consolidation Index and
Hausners ratio
S.NO
TAPPED
DENSITY
BULK
DENSITY
ANGLE
OF
REPOSE
CONSOLI
DATION
INDEX
HAUSNERS
RATIO
F1 0.87 0.74 27.1 14.6 1.18
F2 0.86 0.71 28.5 14.8 1.17
F3 0.81 0.71 29.1 12.5 1.15
F4 0.82 0.73 29.36 12.2 1.14
X-ray Diffraction Studies
Sharp distinct characteristic peaks at 2θ diffraction angles
for Ketoprofen at 11.525°, 14.105°, 18.2560 and 22.190°
indicated its crystalline state (Figure 1). Liquisolid
powder X-ray diffraction pattern (Figure 2-5) showed
absence of these distinct peaks. Hence absence of specific
peaks (constructive reflections) in liquisolid system
revealed that Ketoprofen has been completely converted
to molecular form or solubilized form. This lack of
crystallinity in the formulation might be due to
solubilization of drug in liquid vehicle which was absorbed
into carrier material and adsorbed onto carrier and
coating materials.Whereas, presence of certain ketoprofen
peaks is due to the fact that after saturation of absorption
process, adsorption occurs on the surface of carrier. Thus,
solubilization of ketoprofen in liquisolid system will lead
to improved dissolution rate, and therefore bioavailability
of ketoprofen.
Figure 1: XRD of Ketoprofen pure drug
Figure 2: XRD of Ketoprofen liquisolid compacts prepared
with PG + MCC
4. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
4 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
Figure 3: XRD of Ketoprofen liquisolid compacts prepared
with PG + DCP
Figure 4: XRD of Ketoprofen liquisolid compacts prepared
with Tween 80 + MCC
Figure 5: XRD of Ketoprofen liquisolid compacts prepared
with Tween 80 + DCP
Infra red spectra analysis
The IR spectrum showing percentage transmission (T%)
versus wave number of pure drug is shown in Fig. 6 with
characteristic peaks of aromatic C=O stretching at 1700
cm-1 and 1650 cm-1, respectively. From the figure it is
evident that pure drug in liquisolid compact (Figure 7-10)
undergoes no chemical reaction with any of the excipients
used in the preparation of liquisolid compacts.
Figure 6: FTIR of Ketoprofen pure drug
Figure 7: FTIR of Ketoprofen liquisolid compacts prepared
with PG+DCP
Figure 8: FTIR of Ketoprofen liquisolid compacts prepared
with PG+ MCC
Figure 9: FTIR of Ketoprofen liquisolid compacts prepared
with Tween80 + MCC
Figure 10: FTIR of Ketoprofen liquisolid compacts prepared
with Tween80 + DCP
5. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
5 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
Content Uniformity:
The percentage of drug uniformity was found to be
between 98%-102% of Ketoprofen, Which was within
acceptable limits. The values obtained were given in the
table no. 3
Table 3: Results of Content Uniformity:
Formulations Content uniformity (%)
F1 99.6 + 0.13
F2 100 .3 + 0.13
F3 100.1 + 0.21
F4 101.3 + 0.11
Evaluation of liquisolid tablets
Results of hardness, friability, weight variation and
disintegration time are represented in Table 4. There
should be certain amount of strength or hardness and
resistance to friability for the tablet, so that tablet should
not break during handling.
Table 4: Results of hardness, friability, weight variation and
disintegration time
Formulations Hardness
(kg/cm2)
Friability
(%)
Weight Variation
(%)
Disintegration
Time (min)
F1 5 + 0.2 0.135 + 0.025 526+1.5 3.3 + 0.2
F2 5 + 0.3 0.153 + 0.024 521+1.5 2.5 + 0.4
F3 4 + 0.2 0.212 + 0.032 543+1.5 3.4 + 0.3
F4 4 + 0.3 0.135 + 0.021 533+1.7 2.6 + 0.2
However, it has also effect on tablet disintegration and
drug dissolution. Average hardness of liquisolid tablet
ranges from 3 + 0.2 to 5 + 0.3 kg/cm2. Compactness of
tablet may be due to hydrogen bonding between Avicel PH
101 and drug molecules. As propylene glycol is an
alcoholic compound, it might show hydrogen bonding due
to presence of hydroxyl groups and may contribute to
compactness of tablets. Friability studies of liquisolid
tablets are in the range of 0.125% to 0.292%. This
indicates that acceptable resistance is shown by liquisolid
tablets to withstand handling. Weight variation was found
to be in the range of + 1.5 to + 1.7 for all the formulations,
indicating that all formulations passed the test.
Disintegration time was found to be in the range of 2.5 +
0.4 to 3.4 + 0.3 min. Faster disintegration time indicate
rapid release rates. These are in accordance with
dissolution rates.
Table 5: Results of % Drug Release of various formulations
of Ketoprofen
Formulation
% Drug Release after
10min 20min 30min 45min
F1 32.68 57.96 79.54 99.35
F2 39.17 64.12 84.06 97.70
F3 48.55 68.07 92.02 100.59
F4 56.28 88.51 100.62 -----
Pure Drug 16.46 24.70 45.35 63.97
Marketed 26.72 42.89 77.53 100.60
In vitro dissolution studies
Dissolution rates of liquisolid formulations were
compared with pure drug and marketed formulation
(Table 5). Liquisolid formulations initially show greater
release than marketed formulation. All liquisolid tablets
show greater than 98% drug release after 30 min.
However, marketed formulations show less drug release
at this time. According to “Diffusion layer model” for
dissolution, dissolution rate is in proportion to
concentration gradient in stagnant diffusion layer. Not
only the concentration gradient, drug dissolution is
directly proportional to surface area available for
dissolution. As liquisolid tablets contain a drug dissolved
in nonvolatile solvent, the drug surface available for
dissolution is highly increased. In short, drug is present in
the form of molecular dispersion, after its disintegration in
the dissolution media. As all the dissolution tests for
Ketoprofen liquisolid tablets were conducted at constant
speed (50 rpm) and in same dissolution medium, the
thickness of stagnant diffusion later and diffusion
coefficient for drug dissolution will be almost identical.
Hence, molecularly dispersed drug in liquisolid tablets
may be responsible for greater dissolution rates compared
to marketed formulations. This will also reflect enhanced
oral bioavailability.
Figure 11: DissolutionGraph of Liquisolid Formulations
Figure 12: Comparative Dissolution Graph of Ketoprofen
Conclusion:
The liquisolid tablet technique can be effective way for
dissolution rate improvement of water insoluble drugs
such as Ketoprofen.. Enhanced dissolution rates obtained
in the present study in turn indicates increase in oral
bioavailability due to increased wetting and surface area
available for dissolution. It can be concluded that
formulation containing tween 80 as solvent DCP as carrier
6. Nagabandi Vijay kumar et. al. / JPBMS, 2011, 9 (12)
6 Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 09, Issue 09
material (F-4) has shown faster dissolution than
remaining formulations. This novel approach to the
formulation may be helpful to improve oral bioavailability.
Acknowledgements:
The authors are thankful to the Ranbaxy Pharmaceuticals,
India, and Osaka Pharmaceutical limited, India for
providing gift samples of the drug and polymers.
References:
1.Karmarkar AB, Gonjari ID, Hosmani AH. Liquisolid
technology for dissolution rate enhancement or sustained
release. Expert Opin Drug Deliv. 2010; 7:1227-34.
2.Ajit S. Kulkarni, Nagesh H. Aloorkar, Madhav S. Mane and
Jayashree B. Gaja Liquisolid Systems. Volume 3 April –
June 2010
3.Spireas SS, Wang T, Grover R. Effect of powder substrate
on the dissolution properties of methchrothiazide
liquisolid compacts. Drug Dev Ind Pharm. 1999; 25: 163–
68.
4.Spireas S, Bolton SM. Liquisolid Systems and Methods of
Preparing Same. U.S. Patent, Patent 1999; 5, 968,550.
5.Javadzadeh Y, Siahi MR, Jalali BM, Nokhodchi A.
Enhancement of dissolution rate of piroxicam using
liquisolid compacts. Il Farmaco. 2005; 60: 361–65.
6.Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR,
Barzegar-Jalali M. The effect of type and concentration of
vehicles on the dissolution rate of a poorly soluble drug
(indomethacin) from iquisolid compacts. J Pharm Pharm
Sci. 2005; 8: 18–25.
7.Javadzadeh Y, Siahi MR, Asnaashari S. Nokhodchi A.
Liquidsolid technique as a tool for enhancement of poorly
water-soluble drugs and evaluation of their
physiochemical properties. Acta Pharm. 2007; 57: 99–109.
8.Tiong N, Elkordy AA. Effects of liquisolid formulations on
dissolution of naproxen. Eur J Pharm Biopharm. 2009; 73:
373–84.
9.Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A.
Liquisolid technique for dissolution rate enhancement of a
high dose water-insoluble drug (carbamazepine). Int J
Pharm. 2007; 341: 26–34.
10.Spireas S, Sadu S. Enhancement of prednisolone
dissolution properties using liquisolid compacts. Int J
Pharm. 1998; 166: 177–88.
11.Tayel SA, Soliman II, Louis D. Improvement of
dissolution properties of Carbamazepine through
application of the liquisolid tablet technique. Eur J Pharm
Biopharm. 2008; 69: 342–47.
12.Fahmy RH, Kassem MA. Enhancement of famotidine
dissolution rate through liquisolid tablets for mulation: In
vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;
69: 993–1003.
13.Abdel-Hamid ME. High-performance liquid
chromatography–mass spectrometric analysis of
furosemide in plasma and its use in pharmacokinetic
studies. Il Farmaco. 2000; 55: 448–54.
14.Jackson EK. Goodman and Gilman's the
Pharmacological Basis of therapeutics. McGraw-Hill, New
York, 1996.
15.Hammarlund MM, Paalzow LK, Odlind B.
Pharamcokinetics of furosemide in man after intravenous
and oral administration. Application of moment analysis.
Eur J Clin Pharmacol. 1984; 26: 197–07.
16.El-Gizawy SA. Effect of formulation additives in the
dissolution of Meloxicam from Liquid solid tablets. Egypt J
Biomed Sci. 2007; 25: 143–58.
17.Lin JC, Wang CY. Effects of surfactant treatment of
silver powder on the rheology of its thick-film paste. Mater
Chem Phys. 1996; 45: 136–44.
Corresponding Author:-
Vijaykumar Nagabandi.,
Assistant Professor, Department of Pharmaceutics
Vaageswari College of Pharmacy, Karimnagar, A.P-505481,
India.
Contact no:-919705030917.